(August 22, 2023, 1:35 PM EDT) -- PHILADELPHIA — A U.S. attorney on Aug. 21 filed two deferred prosecution agreements with drugmakers Teva Pharmaceuticals USA Inc. and Glenmark Pharmaceuticals Inc. USA in which the defendants agree to pay a total of $305 million in criminal penalties and donate generic drugs to resolve criminal complaints that they conspired to fix prices and allocate market share for three generic drugs....